These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 18936931

  • 1. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
    Wang Y, Wang C, Li J, Wang X, Zhu G, Chen X, Bi H, Huang M.
    Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
    [Abstract] [Full Text] [Related]

  • 2. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
    Wang YX, Li JL, Wang XD, Zhang Y, Wang CX, Huang M.
    Acta Pharmacol Sin; 2015 Jul; 36(7):855-62. PubMed ID: 25891084
    [Abstract] [Full Text] [Related]

  • 3. The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.
    Haufroid V, Mourad M, Van Kerckhove V, Wawrzyniak J, De Meyer M, Eddour DC, Malaise J, Lison D, Squifflet JP, Wallemacq P.
    Pharmacogenetics; 2004 Mar; 14(3):147-54. PubMed ID: 15167702
    [Abstract] [Full Text] [Related]

  • 4. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.
    Qiu XY, Jiao Z, Zhang M, Zhong LJ, Liang HQ, Ma CL, Zhang L, Zhong MK.
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1069-84. PubMed ID: 18636247
    [Abstract] [Full Text] [Related]

  • 5. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.
    Zhang Y, Li JL, Fu Q, Wang XD, Liu LS, Wang CX, Xie W, Chen ZJ, Shu WY, Huang M.
    Acta Pharmacol Sin; 2013 Apr; 34(4):555-60. PubMed ID: 23503472
    [Abstract] [Full Text] [Related]

  • 6. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.
    Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu JH, Wang D, Li Z, He J, Zhong GP, Zhou G, Zhou HH.
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1093-8. PubMed ID: 17042920
    [Abstract] [Full Text] [Related]

  • 7. Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients.
    Qiu F, He XJ, Sun YX, Li-Ling J, Zhao LM.
    Pharmacol Rep; 2011 Nov; 63(3):815-25. PubMed ID: 21857093
    [Abstract] [Full Text] [Related]

  • 8. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Büchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P.
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [Abstract] [Full Text] [Related]

  • 9. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F.
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [Abstract] [Full Text] [Related]

  • 10. Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.
    Zhou LY, Zuo XC, Chen K, Wang JL, Chen QJ, Zhou YN, Yuan H, Ma Y, Zhu LJ, Peng YX, Ming YZ.
    J Clin Pharm Ther; 2016 Jun; 41(3):341-7. PubMed ID: 27149910
    [Abstract] [Full Text] [Related]

  • 11. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.
    Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A, Shastri SS, Biswas NR, Gupta YK.
    Pharmacol Res; 2017 Jun; 120():138-145. PubMed ID: 28330783
    [Abstract] [Full Text] [Related]

  • 12. Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tsuchiya N, Satoh S, Tada H, Li Z, Ohyama C, Sato K, Suzuki T, Habuchi T, Kato T.
    Transplantation; 2004 Oct 27; 78(8):1182-7. PubMed ID: 15502717
    [Abstract] [Full Text] [Related]

  • 13. Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients.
    Chen B, Zhang W, Fang J, Jin Z, Li J, Yu Z, Cai W.
    Xenobiotica; 2009 Dec 27; 39(12):931-8. PubMed ID: 19925383
    [Abstract] [Full Text] [Related]

  • 14. Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.
    Meng XG, Guo CX, Feng GQ, Zhao YC, Zhou BT, Han JL, Chen X, Shi Y, Shi HY, Yin JY, Peng XD, Pei Q, Zhang W, Wang G, He M, Liu M, Yang JK, Zhou HH.
    Acta Pharmacol Sin; 2012 Dec 27; 33(12):1563-70. PubMed ID: 23085740
    [Abstract] [Full Text] [Related]

  • 15. Conversion from Twice-Daily Prograf® to Once-Daily Advagraf® in Multi-ethnic Asian Adult Renal Transplant Recipients With or Without Concomitant Use of Diltiazem: Impact of CYP3A5 and MDR1 Genetic Polymorphisms on Tacrolimus Exposure.
    Yau WP, Loh CW, Vathsala A.
    Eur J Drug Metab Pharmacokinet; 2019 Aug 27; 44(4):481-492. PubMed ID: 30471066
    [Abstract] [Full Text] [Related]

  • 16. Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.
    Sharaki O, Zeid M, Moez P, Zakaria NH, Nassar E.
    Mol Biol Rep; 2015 Jan 27; 42(1):105-17. PubMed ID: 25240575
    [Abstract] [Full Text] [Related]

  • 17. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X, Liu ZH, Zheng JM, Chen ZH, Tang Z, Chen JS, Li LS.
    Clin Transplant; 2005 Oct 27; 19(5):638-43. PubMed ID: 16146556
    [Abstract] [Full Text] [Related]

  • 18. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT, Lou HX, Zhao Y, Chin YM, Vathsala A.
    Transplant Proc; 2008 Jun 27; 40(5):1690-5. PubMed ID: 18589174
    [Abstract] [Full Text] [Related]

  • 19. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.
    Li DY, Teng RC, Zhu HJ, Fang Y.
    Int J Clin Pharmacol Ther; 2013 Jun 27; 51(6):466-74. PubMed ID: 23557867
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients.
    Chen B, Zhang W, Gu Z, Li J, Zhang Y, Cai W.
    Eur J Clin Pharmacol; 2011 Jun 27; 67(6):601-12. PubMed ID: 21161198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.